Literature DB >> 11882685

CD59 blocks not only the insertion of C9 into MAC but inhibits ion channel formation by homologous C5b-8 as well as C5b-9.

Imre Farkas1, Lajos Baranyi, Yasushige Ishikawa, Noriko Okada, Csaba Bohata, Denes Budai, Atsuo Fukuda, Masaki Imai, Hidechika Okada.   

Abstract

Activation of the complement system on the cell surface results in the insertion of pore forming membrane attack complexes (MAC, C5b-9). In order to protect themselves from the complement attack, the cells express several regulatory molecules, including the terminal complex regulator CD59 that inhibits assembly of the large MACs by inhibiting the insertion of additional C9 molecules into the C5b-9 complex. Using the whole cell patch clamp method, we were able to measure accumulation of homologous MACs in the membrane of CD59(-) human B-cells, which formed non-selective ion channels with a total conductance of 360 +/- 24 pS as measured at the beginning of the steady-state phase of the inward currents. C5b-8 and small-size MAC (MAC containing only a single C9) can also form ion channels. Nevertheless, in CD59(+) human B-cells in spite of small-size MAC formation, an ion current could not be detected. In addition, restoring CD59 to the membrane of the CD59(-) cells inhibited the serum-evoked inward current. The ion channels formed by the small-size MAC were therefore sealed, indicating that CD59 directly interfered with the pore formation of C5b-8 as well as that of small-size C5b-9. These results offer an explanation as to why CD59-expressing cells are not leaky in spite of a buildup of homologous C5b-8 and small-size MAC. Our experiments also confirmed that ion channel inhibition by CD59 is subject to homologous restriction and that CD59 cannot block the conductivity of MAC when generated by xenogenic (rabbit) serum.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11882685      PMCID: PMC2290142          DOI: 10.1113/jphysiol.2001.013381

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  45 in total

Review 1.  Expression of complement in the brain: role in health and disease.

Authors:  B P Morgan; P Gasque
Journal:  Immunol Today       Date:  1996-10

2.  Up-regulated expression of decay-accelerating factor (CD55) confers increased complement resistance to sprouting neural cells.

Authors:  K Z Zhang; S Junnikkala; M G Erlander; H Guo; J A Westberg; S Meri; L C Andersson
Journal:  Eur J Immunol       Date:  1998-04       Impact factor: 5.532

3.  Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-kappa B activation.

Authors:  K S Kilgore; E Schmid; T P Shanley; C M Flory; V Maheswari; N L Tramontini; H Cohen; P A Ward; H P Friedl; J S Warren
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

4.  Cellular immunity to beta 2-glycoprotein-1 in patients with the antiphospholipid syndrome.

Authors:  S Visvanathan; H P McNeil
Journal:  J Immunol       Date:  1999-06-01       Impact factor: 5.422

5.  Unique expression of HRF20 (CD59) in human nervous tissue.

Authors:  H Akatsu; T Yamada; N Okada; T Yamamoto; M Yamashina; H Okada
Journal:  Microbiol Immunol       Date:  1997       Impact factor: 1.955

6.  Complement regulators C1 inhibitor and CD59 do not significantly inhibit complement activation in Alzheimer disease.

Authors:  K Yasojima; E G McGeer; P L McGeer
Journal:  Brain Res       Date:  1999-07-03       Impact factor: 3.252

7.  Activation of Ras and mitogen-activated protein kinase pathway by terminal complement complexes is G protein dependent.

Authors:  F Niculescu; H Rus; T van Biesen; M L Shin
Journal:  J Immunol       Date:  1997-05-01       Impact factor: 5.422

8.  Mapping the active site of CD59.

Authors:  J Yu; R Abagyan; S Dong; A Gilbert; V Nussenzweig; S Tomlinson
Journal:  J Exp Med       Date:  1997-02-17       Impact factor: 14.307

9.  Identity of the segment of human complement C8 recognized by complement regulatory protein CD59.

Authors:  D H Lockert; K M Kaufman; C P Chang; T Hüsler; J M Sodetz; P J Sims
Journal:  J Biol Chem       Date:  1995-08-25       Impact factor: 5.157

10.  Complement-mediated neurotoxicity is regulated by homologous restriction.

Authors:  Y Shen; J A Halperin; C M Lee
Journal:  Brain Res       Date:  1995-02-13       Impact factor: 3.252

View more
  47 in total

Review 1.  Protein engineering to target complement evasion in cancer.

Authors:  Darrick Carter; André Lieber
Journal:  FEBS Lett       Date:  2013-11-14       Impact factor: 4.124

2.  Proteomic Profiling of Native Unpassaged and Culture-Expanded Mesenchymal Stromal Cells (MSC).

Authors:  Erika Moravcikova; E Michael Meyer; Mirko Corselli; Vera S Donnenberg; Albert D Donnenberg
Journal:  Cytometry A       Date:  2018-09-13       Impact factor: 4.355

3.  4-Hydroxy-7-oxo-5-heptenoic Acid Lactone Is a Potent Inducer of the Complement Pathway in Human Retinal Pigmented Epithelial Cells.

Authors:  Mikhail Linetsky; Karina S Bondelid; Sofiya Losovskiy; Vadym Gabyak; Mario J Rullo; Thomas I Stiadle; Vasu Munjapara; Priyali Saxena; Duoming Ma; Yu-Shiuan Cheng; Andrew M Howes; Emeka Udeigwe; Robert G Salomon
Journal:  Chem Res Toxicol       Date:  2018-07-09       Impact factor: 3.739

4.  Aptamer–biotin–streptavidin–C1q complexes can trigger the classical complement pathway to kill cancer cells.

Authors:  John Gordon Bruno
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-02       Impact factor: 2.416

5.  Cutting edge: murine CD59a modulates antiviral CD4+ T cell activity in a complement-independent manner.

Authors:  M Paula Longhi; Baalasubramanian Sivasankar; Nader Omidvar; B Paul Morgan; Awen Gallimore
Journal:  J Immunol       Date:  2005-12-01       Impact factor: 5.422

Review 6.  A novel perspective on stem cell homing and mobilization: review on bioactive lipids as potent chemoattractants and cationic peptides as underappreciated modulators of responsiveness to SDF-1 gradients.

Authors:  M Z Ratajczak; C H Kim; A Abdel-Latif; G Schneider; M Kucia; A J Morris; M J Laughlin; J Ratajczak
Journal:  Leukemia       Date:  2011-09-02       Impact factor: 11.528

Review 7.  How novel structures inform understanding of complement function.

Authors:  Elena Goicoechea de Jorge; Hugo Yebenes; Marina Serna; Agustín Tortajada; Oscar Llorca; Santiago Rodríguez de Córdoba
Journal:  Semin Immunopathol       Date:  2017-08-14       Impact factor: 9.623

8.  Remarkable Activation of the Complement System and Aberrant Neuronal Localization of the Membrane Attack Complex in the Brain Tissues of Scrapie-Infected Rodents.

Authors:  Yan Lv; Cao Chen; Bao-Yun Zhang; Kang Xiao; Jing Wang; Li-Na Chen; Jing Sun; Chen Gao; Qi Shi; Xiao-Ping Dong
Journal:  Mol Neurobiol       Date:  2014-10-14       Impact factor: 5.590

9.  Intermedilysin-receptor interactions during assembly of the pore complex: assembly intermediates increase host cell susceptibility to complement-mediated lysis.

Authors:  Stephanie LaChapelle; Rodney K Tweten; Eileen M Hotze
Journal:  J Biol Chem       Date:  2009-03-16       Impact factor: 5.157

10.  Inhibition of the complement membrane attack complex by Schistosoma mansoni paramyosin.

Authors:  Jiusheng Deng; Daniel Gold; Philip T LoVerde; Zvi Fishelson
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.